IVAN ROSAS to Clinical Trials, Phase IV as Topic
This is a "connection" page, showing publications IVAN ROSAS has written about Clinical Trials, Phase IV as Topic.
Connection Strength
0.061
-
Early nintedanib deployment in COVID-19 interstitial lung disease (ENDCOV-I): study protocol of a randomised, double-blind, placebo-controlled trial. BMJ Open Respir Res. 2025 Apr 10; 12(1).
Score: 0.061